THY1 and neoplasm: The CD133 subpopulations displayed similar expression for CD29 (integrin β1), CD49f (integrin α6), CD90, and CD117 (c-kit: gastrointestinal stroma tumor), indicating these makers are still not definitive TIC markers (Ma et al., 2007).